Global Rare NGR1 Fusion Market Growth (Status and Outlook) 2026-2032
The global Rare NGR1 Fusion market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
NGR1 fusion, also known as NTRK1 fusion, is a genetic alteration in which the NTRK1 gene fuses with another gene, resulting in an abnormal fusion protein. The NTRK1 gene is part of the neurotrophic tyrosine receptor kinase (NTRK) family, which plays a crucial role in the development and functioning of nerve cells. NTRK1 fusions can lead to uncontrolled cell growth and are associated with certain rare cancer types.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
LPI (LP Information)' newest research report, the “Rare NGR1 Fusion Industry Forecast” looks at past sales and reviews total world Rare NGR1 Fusion sales in 2025, providing a comprehensive analysis by region and market sector of projected Rare NGR1 Fusion sales for 2026 through 2032. With Rare NGR1 Fusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rare NGR1 Fusion industry.
This Insight Report provides a comprehensive analysis of the global Rare NGR1 Fusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rare NGR1 Fusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare NGR1 Fusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare NGR1 Fusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare NGR1 Fusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare NGR1 Fusion market by product type, application, key players and key regions and countries.
Segmentation by Type:
NGR1 fusion, also known as NTRK1 fusion, is a genetic alteration in which the NTRK1 gene fuses with another gene, resulting in an abnormal fusion protein. The NTRK1 gene is part of the neurotrophic tyrosine receptor kinase (NTRK) family, which plays a crucial role in the development and functioning of nerve cells. NTRK1 fusions can lead to uncontrolled cell growth and are associated with certain rare cancer types.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
LPI (LP Information)' newest research report, the “Rare NGR1 Fusion Industry Forecast” looks at past sales and reviews total world Rare NGR1 Fusion sales in 2025, providing a comprehensive analysis by region and market sector of projected Rare NGR1 Fusion sales for 2026 through 2032. With Rare NGR1 Fusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rare NGR1 Fusion industry.
This Insight Report provides a comprehensive analysis of the global Rare NGR1 Fusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rare NGR1 Fusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare NGR1 Fusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare NGR1 Fusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare NGR1 Fusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare NGR1 Fusion market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immunotherapy
- Chemotherapy
- Radiation Therapy
- Hospital
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Elevation Oncology
- Merus
- Hummingbird Bioscience
- Boehringer Ingelheim
- CANbridge Pharmaceuticals
- Salubris Biotherapeutics
- AVEO Oncology
- Rain Therapeutics
- Eli Lilly and Company
- Jiangsu Hengrui Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rare NGR1 Fusion Market Size (2021-2032)
2.1.2 Rare NGR1 Fusion Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Rare NGR1 Fusion by Country/Region (2021, 2025 & 2032)
2.2 Rare NGR1 Fusion Segment by Type
2.2.1 Immunotherapy
2.2.2 Chemotherapy
2.2.3 Radiation Therapy
2.2.4 Rare NGR1 Fusion Market Size by Type
2.2.4.1 Rare NGR1 Fusion Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
2.3 Rare NGR1 Fusion Segment by Application
2.3.1 Hospital
2.3.2 Clinics
2.3.3 Others
2.3.4 Rare NGR1 Fusion Market Size by Application
2.3.4.1 Rare NGR1 Fusion Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
3 RARE NGR1 FUSION MARKET SIZE BY PLAYER
3.1 Rare NGR1 Fusion Market Size Market Share by Player
3.1.1 Global Rare NGR1 Fusion Revenue by Player (2021-2026)
3.1.2 Global Rare NGR1 Fusion Revenue Market Share by Player (2021-2026)
3.2 Global Rare NGR1 Fusion Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RARE NGR1 FUSION BY REGION
4.1 Rare NGR1 Fusion Market Size by Region (2021-2026)
4.2 Global Rare NGR1 Fusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rare NGR1 Fusion Market Size Growth (2021-2026)
4.4 APAC Rare NGR1 Fusion Market Size Growth (2021-2026)
4.5 Europe Rare NGR1 Fusion Market Size Growth (2021-2026)
4.6 Middle East & Africa Rare NGR1 Fusion Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Rare NGR1 Fusion Market Size by Country (2021-2026)
5.2 Americas Rare NGR1 Fusion Market Size by Type (2021-2026)
5.3 Americas Rare NGR1 Fusion Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rare NGR1 Fusion Market Size by Region (2021-2026)
6.2 APAC Rare NGR1 Fusion Market Size by Type (2021-2026)
6.3 APAC Rare NGR1 Fusion Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Rare NGR1 Fusion Market Size by Country (2021-2026)
7.2 Europe Rare NGR1 Fusion Market Size by Type (2021-2026)
7.3 Europe Rare NGR1 Fusion Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rare NGR1 Fusion by Region (2021-2026)
8.2 Middle East & Africa Rare NGR1 Fusion Market Size by Type (2021-2026)
8.3 Middle East & Africa Rare NGR1 Fusion Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RARE NGR1 FUSION MARKET FORECAST
10.1 Global Rare NGR1 Fusion Forecast by Region (2027-2032)
10.1.1 Global Rare NGR1 Fusion Forecast by Region (2027-2032)
10.1.2 Americas Rare NGR1 Fusion Forecast
10.1.3 APAC Rare NGR1 Fusion Forecast
10.1.4 Europe Rare NGR1 Fusion Forecast
10.1.5 Middle East & Africa Rare NGR1 Fusion Forecast
10.2 Americas Rare NGR1 Fusion Forecast by Country (2027-2032)
10.2.1 United States Market Rare NGR1 Fusion Forecast
10.2.2 Canada Market Rare NGR1 Fusion Forecast
10.2.3 Mexico Market Rare NGR1 Fusion Forecast
10.2.4 Brazil Market Rare NGR1 Fusion Forecast
10.3 APAC Rare NGR1 Fusion Forecast by Region (2027-2032)
10.3.1 China Rare NGR1 Fusion Market Forecast
10.3.2 Japan Market Rare NGR1 Fusion Forecast
10.3.3 Korea Market Rare NGR1 Fusion Forecast
10.3.4 Southeast Asia Market Rare NGR1 Fusion Forecast
10.3.5 India Market Rare NGR1 Fusion Forecast
10.3.6 Australia Market Rare NGR1 Fusion Forecast
10.4 Europe Rare NGR1 Fusion Forecast by Country (2027-2032)
10.4.1 Germany Market Rare NGR1 Fusion Forecast
10.4.2 France Market Rare NGR1 Fusion Forecast
10.4.3 UK Market Rare NGR1 Fusion Forecast
10.4.4 Italy Market Rare NGR1 Fusion Forecast
10.4.5 Russia Market Rare NGR1 Fusion Forecast
10.5 Middle East & Africa Rare NGR1 Fusion Forecast by Region (2027-2032)
10.5.1 Egypt Market Rare NGR1 Fusion Forecast
10.5.2 South Africa Market Rare NGR1 Fusion Forecast
10.5.3 Israel Market Rare NGR1 Fusion Forecast
10.5.4 Turkey Market Rare NGR1 Fusion Forecast
10.6 Global Rare NGR1 Fusion Forecast by Type (2027-2032)
10.7 Global Rare NGR1 Fusion Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Rare NGR1 Fusion Forecast
11 KEY PLAYERS ANALYSIS
11.1 Elevation Oncology
11.1.1 Elevation Oncology Company Information
11.1.2 Elevation Oncology Rare NGR1 Fusion Product Offered
11.1.3 Elevation Oncology Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Elevation Oncology Main Business Overview
11.1.5 Elevation Oncology Latest Developments
11.2 Merus
11.2.1 Merus Company Information
11.2.2 Merus Rare NGR1 Fusion Product Offered
11.2.3 Merus Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merus Main Business Overview
11.2.5 Merus Latest Developments
11.3 Hummingbird Bioscience
11.3.1 Hummingbird Bioscience Company Information
11.3.2 Hummingbird Bioscience Rare NGR1 Fusion Product Offered
11.3.3 Hummingbird Bioscience Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hummingbird Bioscience Main Business Overview
11.3.5 Hummingbird Bioscience Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Rare NGR1 Fusion Product Offered
11.4.3 Boehringer Ingelheim Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 CANbridge Pharmaceuticals
11.5.1 CANbridge Pharmaceuticals Company Information
11.5.2 CANbridge Pharmaceuticals Rare NGR1 Fusion Product Offered
11.5.3 CANbridge Pharmaceuticals Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CANbridge Pharmaceuticals Main Business Overview
11.5.5 CANbridge Pharmaceuticals Latest Developments
11.6 Salubris Biotherapeutics
11.6.1 Salubris Biotherapeutics Company Information
11.6.2 Salubris Biotherapeutics Rare NGR1 Fusion Product Offered
11.6.3 Salubris Biotherapeutics Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Salubris Biotherapeutics Main Business Overview
11.6.5 Salubris Biotherapeutics Latest Developments
11.7 AVEO Oncology
11.7.1 AVEO Oncology Company Information
11.7.2 AVEO Oncology Rare NGR1 Fusion Product Offered
11.7.3 AVEO Oncology Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AVEO Oncology Main Business Overview
11.7.5 AVEO Oncology Latest Developments
11.8 Rain Therapeutics
11.8.1 Rain Therapeutics Company Information
11.8.2 Rain Therapeutics Rare NGR1 Fusion Product Offered
11.8.3 Rain Therapeutics Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Rain Therapeutics Main Business Overview
11.8.5 Rain Therapeutics Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Rare NGR1 Fusion Product Offered
11.9.3 Eli Lilly and Company Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Information
11.10.2 Jiangsu Hengrui Medicine Rare NGR1 Fusion Product Offered
11.10.3 Jiangsu Hengrui Medicine Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Jiangsu Hengrui Medicine Main Business Overview
11.10.5 Jiangsu Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rare NGR1 Fusion Market Size (2021-2032)
2.1.2 Rare NGR1 Fusion Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Rare NGR1 Fusion by Country/Region (2021, 2025 & 2032)
2.2 Rare NGR1 Fusion Segment by Type
2.2.1 Immunotherapy
2.2.2 Chemotherapy
2.2.3 Radiation Therapy
2.2.4 Rare NGR1 Fusion Market Size by Type
2.2.4.1 Rare NGR1 Fusion Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
2.3 Rare NGR1 Fusion Segment by Application
2.3.1 Hospital
2.3.2 Clinics
2.3.3 Others
2.3.4 Rare NGR1 Fusion Market Size by Application
2.3.4.1 Rare NGR1 Fusion Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
3 RARE NGR1 FUSION MARKET SIZE BY PLAYER
3.1 Rare NGR1 Fusion Market Size Market Share by Player
3.1.1 Global Rare NGR1 Fusion Revenue by Player (2021-2026)
3.1.2 Global Rare NGR1 Fusion Revenue Market Share by Player (2021-2026)
3.2 Global Rare NGR1 Fusion Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RARE NGR1 FUSION BY REGION
4.1 Rare NGR1 Fusion Market Size by Region (2021-2026)
4.2 Global Rare NGR1 Fusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rare NGR1 Fusion Market Size Growth (2021-2026)
4.4 APAC Rare NGR1 Fusion Market Size Growth (2021-2026)
4.5 Europe Rare NGR1 Fusion Market Size Growth (2021-2026)
4.6 Middle East & Africa Rare NGR1 Fusion Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Rare NGR1 Fusion Market Size by Country (2021-2026)
5.2 Americas Rare NGR1 Fusion Market Size by Type (2021-2026)
5.3 Americas Rare NGR1 Fusion Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rare NGR1 Fusion Market Size by Region (2021-2026)
6.2 APAC Rare NGR1 Fusion Market Size by Type (2021-2026)
6.3 APAC Rare NGR1 Fusion Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Rare NGR1 Fusion Market Size by Country (2021-2026)
7.2 Europe Rare NGR1 Fusion Market Size by Type (2021-2026)
7.3 Europe Rare NGR1 Fusion Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rare NGR1 Fusion by Region (2021-2026)
8.2 Middle East & Africa Rare NGR1 Fusion Market Size by Type (2021-2026)
8.3 Middle East & Africa Rare NGR1 Fusion Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RARE NGR1 FUSION MARKET FORECAST
10.1 Global Rare NGR1 Fusion Forecast by Region (2027-2032)
10.1.1 Global Rare NGR1 Fusion Forecast by Region (2027-2032)
10.1.2 Americas Rare NGR1 Fusion Forecast
10.1.3 APAC Rare NGR1 Fusion Forecast
10.1.4 Europe Rare NGR1 Fusion Forecast
10.1.5 Middle East & Africa Rare NGR1 Fusion Forecast
10.2 Americas Rare NGR1 Fusion Forecast by Country (2027-2032)
10.2.1 United States Market Rare NGR1 Fusion Forecast
10.2.2 Canada Market Rare NGR1 Fusion Forecast
10.2.3 Mexico Market Rare NGR1 Fusion Forecast
10.2.4 Brazil Market Rare NGR1 Fusion Forecast
10.3 APAC Rare NGR1 Fusion Forecast by Region (2027-2032)
10.3.1 China Rare NGR1 Fusion Market Forecast
10.3.2 Japan Market Rare NGR1 Fusion Forecast
10.3.3 Korea Market Rare NGR1 Fusion Forecast
10.3.4 Southeast Asia Market Rare NGR1 Fusion Forecast
10.3.5 India Market Rare NGR1 Fusion Forecast
10.3.6 Australia Market Rare NGR1 Fusion Forecast
10.4 Europe Rare NGR1 Fusion Forecast by Country (2027-2032)
10.4.1 Germany Market Rare NGR1 Fusion Forecast
10.4.2 France Market Rare NGR1 Fusion Forecast
10.4.3 UK Market Rare NGR1 Fusion Forecast
10.4.4 Italy Market Rare NGR1 Fusion Forecast
10.4.5 Russia Market Rare NGR1 Fusion Forecast
10.5 Middle East & Africa Rare NGR1 Fusion Forecast by Region (2027-2032)
10.5.1 Egypt Market Rare NGR1 Fusion Forecast
10.5.2 South Africa Market Rare NGR1 Fusion Forecast
10.5.3 Israel Market Rare NGR1 Fusion Forecast
10.5.4 Turkey Market Rare NGR1 Fusion Forecast
10.6 Global Rare NGR1 Fusion Forecast by Type (2027-2032)
10.7 Global Rare NGR1 Fusion Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Rare NGR1 Fusion Forecast
11 KEY PLAYERS ANALYSIS
11.1 Elevation Oncology
11.1.1 Elevation Oncology Company Information
11.1.2 Elevation Oncology Rare NGR1 Fusion Product Offered
11.1.3 Elevation Oncology Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Elevation Oncology Main Business Overview
11.1.5 Elevation Oncology Latest Developments
11.2 Merus
11.2.1 Merus Company Information
11.2.2 Merus Rare NGR1 Fusion Product Offered
11.2.3 Merus Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merus Main Business Overview
11.2.5 Merus Latest Developments
11.3 Hummingbird Bioscience
11.3.1 Hummingbird Bioscience Company Information
11.3.2 Hummingbird Bioscience Rare NGR1 Fusion Product Offered
11.3.3 Hummingbird Bioscience Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hummingbird Bioscience Main Business Overview
11.3.5 Hummingbird Bioscience Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Rare NGR1 Fusion Product Offered
11.4.3 Boehringer Ingelheim Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 CANbridge Pharmaceuticals
11.5.1 CANbridge Pharmaceuticals Company Information
11.5.2 CANbridge Pharmaceuticals Rare NGR1 Fusion Product Offered
11.5.3 CANbridge Pharmaceuticals Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CANbridge Pharmaceuticals Main Business Overview
11.5.5 CANbridge Pharmaceuticals Latest Developments
11.6 Salubris Biotherapeutics
11.6.1 Salubris Biotherapeutics Company Information
11.6.2 Salubris Biotherapeutics Rare NGR1 Fusion Product Offered
11.6.3 Salubris Biotherapeutics Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Salubris Biotherapeutics Main Business Overview
11.6.5 Salubris Biotherapeutics Latest Developments
11.7 AVEO Oncology
11.7.1 AVEO Oncology Company Information
11.7.2 AVEO Oncology Rare NGR1 Fusion Product Offered
11.7.3 AVEO Oncology Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AVEO Oncology Main Business Overview
11.7.5 AVEO Oncology Latest Developments
11.8 Rain Therapeutics
11.8.1 Rain Therapeutics Company Information
11.8.2 Rain Therapeutics Rare NGR1 Fusion Product Offered
11.8.3 Rain Therapeutics Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Rain Therapeutics Main Business Overview
11.8.5 Rain Therapeutics Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Rare NGR1 Fusion Product Offered
11.9.3 Eli Lilly and Company Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Information
11.10.2 Jiangsu Hengrui Medicine Rare NGR1 Fusion Product Offered
11.10.3 Jiangsu Hengrui Medicine Rare NGR1 Fusion Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Jiangsu Hengrui Medicine Main Business Overview
11.10.5 Jiangsu Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rare NGR1 Fusion Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Rare NGR1 Fusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunotherapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Radiation Therapy
Table 6. Rare NGR1 Fusion Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Table 9. Rare NGR1 Fusion Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Table 12. Global Rare NGR1 Fusion Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Rare NGR1 Fusion Revenue Market Share by Player (2021-2026)
Table 14. Rare NGR1 Fusion Key Players Head office and Products Offered
Table 15. Rare NGR1 Fusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Table 20. Global Rare NGR1 Fusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Rare NGR1 Fusion Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Rare NGR1 Fusion Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Rare NGR1 Fusion Market Size Market Share by Country (2021-2026)
Table 24. Americas Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Table 26. Americas Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Table 28. APAC Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Table 30. APAC Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Rare NGR1 Fusion Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Rare NGR1 Fusion Market Size Market Share by Country (2021-2026)
Table 34. Europe Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Rare NGR1 Fusion
Table 40. Key Market Challenges & Risks of Rare NGR1 Fusion
Table 41. Key Industry Trends of Rare NGR1 Fusion
Table 42. Global Rare NGR1 Fusion Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Rare NGR1 Fusion Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Rare NGR1 Fusion Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Rare NGR1 Fusion Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Elevation Oncology Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 47. Elevation Oncology Rare NGR1 Fusion Product Offered
Table 48. Elevation Oncology Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Elevation Oncology Main Business
Table 50. Elevation Oncology Latest Developments
Table 51. Merus Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 52. Merus Rare NGR1 Fusion Product Offered
Table 53. Merus Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Merus Main Business
Table 55. Merus Latest Developments
Table 56. Hummingbird Bioscience Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 57. Hummingbird Bioscience Rare NGR1 Fusion Product Offered
Table 58. Hummingbird Bioscience Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Hummingbird Bioscience Main Business
Table 60. Hummingbird Bioscience Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 62. Boehringer Ingelheim Rare NGR1 Fusion Product Offered
Table 63. Boehringer Ingelheim Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Boehringer Ingelheim Main Business
Table 65. Boehringer Ingelheim Latest Developments
Table 66. CANbridge Pharmaceuticals Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 67. CANbridge Pharmaceuticals Rare NGR1 Fusion Product Offered
Table 68. CANbridge Pharmaceuticals Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. CANbridge Pharmaceuticals Main Business
Table 70. CANbridge Pharmaceuticals Latest Developments
Table 71. Salubris Biotherapeutics Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 72. Salubris Biotherapeutics Rare NGR1 Fusion Product Offered
Table 73. Salubris Biotherapeutics Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Salubris Biotherapeutics Main Business
Table 75. Salubris Biotherapeutics Latest Developments
Table 76. AVEO Oncology Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 77. AVEO Oncology Rare NGR1 Fusion Product Offered
Table 78. AVEO Oncology Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. AVEO Oncology Main Business
Table 80. AVEO Oncology Latest Developments
Table 81. Rain Therapeutics Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 82. Rain Therapeutics Rare NGR1 Fusion Product Offered
Table 83. Rain Therapeutics Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Rain Therapeutics Main Business
Table 85. Rain Therapeutics Latest Developments
Table 86. Eli Lilly and Company Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 87. Eli Lilly and Company Rare NGR1 Fusion Product Offered
Table 88. Eli Lilly and Company Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Eli Lilly and Company Main Business
Table 90. Eli Lilly and Company Latest Developments
Table 91. Jiangsu Hengrui Medicine Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 92. Jiangsu Hengrui Medicine Rare NGR1 Fusion Product Offered
Table 93. Jiangsu Hengrui Medicine Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Main Business
Table 95. Jiangsu Hengrui Medicine Latest Developments
Table 1. Rare NGR1 Fusion Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Rare NGR1 Fusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunotherapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Radiation Therapy
Table 6. Rare NGR1 Fusion Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Table 9. Rare NGR1 Fusion Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Table 12. Global Rare NGR1 Fusion Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Rare NGR1 Fusion Revenue Market Share by Player (2021-2026)
Table 14. Rare NGR1 Fusion Key Players Head office and Products Offered
Table 15. Rare NGR1 Fusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Table 20. Global Rare NGR1 Fusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Rare NGR1 Fusion Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Rare NGR1 Fusion Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Rare NGR1 Fusion Market Size Market Share by Country (2021-2026)
Table 24. Americas Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Table 26. Americas Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Table 28. APAC Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Table 30. APAC Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Rare NGR1 Fusion Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Rare NGR1 Fusion Market Size Market Share by Country (2021-2026)
Table 34. Europe Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Rare NGR1 Fusion Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Rare NGR1 Fusion Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Rare NGR1 Fusion Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Rare NGR1 Fusion
Table 40. Key Market Challenges & Risks of Rare NGR1 Fusion
Table 41. Key Industry Trends of Rare NGR1 Fusion
Table 42. Global Rare NGR1 Fusion Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Rare NGR1 Fusion Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Rare NGR1 Fusion Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Rare NGR1 Fusion Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Elevation Oncology Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 47. Elevation Oncology Rare NGR1 Fusion Product Offered
Table 48. Elevation Oncology Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Elevation Oncology Main Business
Table 50. Elevation Oncology Latest Developments
Table 51. Merus Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 52. Merus Rare NGR1 Fusion Product Offered
Table 53. Merus Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Merus Main Business
Table 55. Merus Latest Developments
Table 56. Hummingbird Bioscience Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 57. Hummingbird Bioscience Rare NGR1 Fusion Product Offered
Table 58. Hummingbird Bioscience Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Hummingbird Bioscience Main Business
Table 60. Hummingbird Bioscience Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 62. Boehringer Ingelheim Rare NGR1 Fusion Product Offered
Table 63. Boehringer Ingelheim Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Boehringer Ingelheim Main Business
Table 65. Boehringer Ingelheim Latest Developments
Table 66. CANbridge Pharmaceuticals Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 67. CANbridge Pharmaceuticals Rare NGR1 Fusion Product Offered
Table 68. CANbridge Pharmaceuticals Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. CANbridge Pharmaceuticals Main Business
Table 70. CANbridge Pharmaceuticals Latest Developments
Table 71. Salubris Biotherapeutics Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 72. Salubris Biotherapeutics Rare NGR1 Fusion Product Offered
Table 73. Salubris Biotherapeutics Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Salubris Biotherapeutics Main Business
Table 75. Salubris Biotherapeutics Latest Developments
Table 76. AVEO Oncology Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 77. AVEO Oncology Rare NGR1 Fusion Product Offered
Table 78. AVEO Oncology Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. AVEO Oncology Main Business
Table 80. AVEO Oncology Latest Developments
Table 81. Rain Therapeutics Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 82. Rain Therapeutics Rare NGR1 Fusion Product Offered
Table 83. Rain Therapeutics Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Rain Therapeutics Main Business
Table 85. Rain Therapeutics Latest Developments
Table 86. Eli Lilly and Company Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 87. Eli Lilly and Company Rare NGR1 Fusion Product Offered
Table 88. Eli Lilly and Company Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Eli Lilly and Company Main Business
Table 90. Eli Lilly and Company Latest Developments
Table 91. Jiangsu Hengrui Medicine Details, Company Type, Rare NGR1 Fusion Area Served and Its Competitors
Table 92. Jiangsu Hengrui Medicine Rare NGR1 Fusion Product Offered
Table 93. Jiangsu Hengrui Medicine Rare NGR1 Fusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Main Business
Table 95. Jiangsu Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Rare NGR1 Fusion Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare NGR1 Fusion Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Rare NGR1 Fusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Rare NGR1 Fusion Sales Market Share by Country/Region (2025)
Figure 8. Rare NGR1 Fusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Rare NGR1 Fusion Market Size Market Share by Type in 2025
Figure 10. Rare NGR1 Fusion in Hospital
Figure 11. Global Rare NGR1 Fusion Market: Hospital (2021-2026) & ($ millions)
Figure 12. Rare NGR1 Fusion in Clinics
Figure 13. Global Rare NGR1 Fusion Market: Clinics (2021-2026) & ($ millions)
Figure 14. Rare NGR1 Fusion in Others
Figure 15. Global Rare NGR1 Fusion Market: Others (2021-2026) & ($ millions)
Figure 16. Global Rare NGR1 Fusion Market Size Market Share by Application in 2025
Figure 17. Global Rare NGR1 Fusion Revenue Market Share by Player in 2025
Figure 18. Global Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Figure 19. Americas Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 20. APAC Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 21. Europe Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 23. Americas Rare NGR1 Fusion Value Market Share by Country in 2025
Figure 24. United States Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Rare NGR1 Fusion Market Size Market Share by Region in 2025
Figure 29. APAC Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 30. APAC Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 31. China Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 35. India Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Rare NGR1 Fusion Market Size Market Share by Country in 2025
Figure 38. Europe Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 39. Europe Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 40. Germany Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 41. France Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 54. APAC Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 55. Europe Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 57. United States Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 58. Canada Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 59. Mexico Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 60. Brazil Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 61. China Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 62. Japan Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 63. Korea Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 65. India Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 66. Australia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 67. Germany Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 68. France Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 69. UK Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 70. Italy Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 71. Russia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 72. Egypt Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 73. South Africa Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 74. Israel Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 75. Turkey Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 76. Global Rare NGR1 Fusion Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Rare NGR1 Fusion Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 1. Rare NGR1 Fusion Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare NGR1 Fusion Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Rare NGR1 Fusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Rare NGR1 Fusion Sales Market Share by Country/Region (2025)
Figure 8. Rare NGR1 Fusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Rare NGR1 Fusion Market Size Market Share by Type in 2025
Figure 10. Rare NGR1 Fusion in Hospital
Figure 11. Global Rare NGR1 Fusion Market: Hospital (2021-2026) & ($ millions)
Figure 12. Rare NGR1 Fusion in Clinics
Figure 13. Global Rare NGR1 Fusion Market: Clinics (2021-2026) & ($ millions)
Figure 14. Rare NGR1 Fusion in Others
Figure 15. Global Rare NGR1 Fusion Market: Others (2021-2026) & ($ millions)
Figure 16. Global Rare NGR1 Fusion Market Size Market Share by Application in 2025
Figure 17. Global Rare NGR1 Fusion Revenue Market Share by Player in 2025
Figure 18. Global Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Figure 19. Americas Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 20. APAC Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 21. Europe Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Rare NGR1 Fusion Market Size 2021-2026 ($ millions)
Figure 23. Americas Rare NGR1 Fusion Value Market Share by Country in 2025
Figure 24. United States Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Rare NGR1 Fusion Market Size Market Share by Region in 2025
Figure 29. APAC Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 30. APAC Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 31. China Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 35. India Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Rare NGR1 Fusion Market Size Market Share by Country in 2025
Figure 38. Europe Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 39. Europe Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 40. Germany Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 41. France Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Rare NGR1 Fusion Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Rare NGR1 Fusion Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 54. APAC Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 55. Europe Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 57. United States Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 58. Canada Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 59. Mexico Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 60. Brazil Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 61. China Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 62. Japan Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 63. Korea Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 65. India Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 66. Australia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 67. Germany Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 68. France Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 69. UK Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 70. Italy Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 71. Russia Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 72. Egypt Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 73. South Africa Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 74. Israel Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 75. Turkey Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
Figure 76. Global Rare NGR1 Fusion Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Rare NGR1 Fusion Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Rare NGR1 Fusion Market Size 2027-2032 ($ millions)
